A bipartisan group of six senators yesterday urged Senate leadership to include in a year-end package, legislation that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B drug savings program. The Centers for Medicare & Medicaid Services last month finalized a rule that reduces by nearly 30%, or $1.6 billion, Medicare payments to certain public and non-profit hospitals for outpatient drugs purchased under the 340B program. “As talks continue on end of the year packages, we urge you to work with us to prevent these cuts,” the senators wrote to Senate Majority Leader Mitch McConnell (R-KY) and Minority Leader Chuck Schumer (D-NY). Sens. John Thune (R-SD), Rob Portman (R-OH), Shelley Moore Capito (R-WV), Debbie Stabenow (D-MI), Tammy Baldwin (D-WI) and Bill Nelson (D-FL) signed the letter. Reps. David McKinley (R-WV) and Mike Thompson (D-CA) have introduced H.R. 4392, a bill that would prevent the cuts to the 340B program from being implemented.

Headline
 The AHA March 3 urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk policy from taking effect…
Headline
The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on its request for information on…
Headline
The U.S. District Court for the District of Hawaii Feb. 23 denied a preliminary injunction requested by AstraZeneca in a case challenging the state’s law…
Headline
The AHA, joined by several other national groups representing 340B hospitals, Feb. 19 urged the Health Resources and Services Administration to extend the…
Headline
The Minnesota Court of Appeals Feb. 17 affirmed a lower court decision in ruling that the state’s 340B contract pharmacy law is not preempted by federal law.…
Headline
The Department of Health and Human Services Feb. 13 issued a request for information on a new 340B rebate model program. The RFI said HHS’ Health Resources and…